What evidence proves that your research has driven significant changes in cancer treatments?

There is no closed list of documents that EB-2 NIW requires to prove the impact of oncology research. What matters is the body of evidence that, taken together, verifiably demonstrates that your work had relevance and reach beyond the laboratory. These documents serve as support for the petition and are evaluated case by case by the adjudicating authority.

Among the types of evidence that typically sustain this kind of argument are:

• Publications in peer-reviewed scientific journals and the citations they receive from other researchers.
• Presentations at conferences and symposia that bring together experts in the field.
• Awards and recognition from respected institutions and associations in healthcare.
• Partnerships with hospitals, universities, and research centers that brought the results into clinical practice.
• Recommendation letters from recognized leaders in oncology and, when applicable, patents or licenses derived from the work.

The central point is connecting each document to a clear narrative: what the research changed, for whom, and with what reach. Organizing this evidence objectively helps the adjudicator see the contribution without ambiguity.

Since each case is analyzed individually, it is worth verifying the updated requirements with USCIS and assessing your profile with a specialist before assembling the petition package.

About the author

Victoria Harper

Editor-in-Chief

Meet the author

As a journalist and lead editor at Visto n’ Visa, Victoria helps ensure that immigration topics are covered in a clear, trustworthy, and easy-to-understand way. Her focus is on delivering useful, human, and relevant content for people exploring new paths abroad.